Exact Mass: 419.3563

Exact Mass Matches: 419.3563

Found 42 metabolites which its exact mass value is equals to given mass value 419.3563, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Oleoyl Histidine

2-[(1-Hydroxyoctadec-9-en-1-ylidene)amino]-3-(1H-imidazol-5-yl)propanoate

C24H41N3O3 (419.3148)


N-oleoyl histidine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Oleic acid amide of Histidine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Oleoyl Histidine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Oleoyl Histidine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Sarar

N1-[(4-aminophenyl)methyl]-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1,8-diamine

C21H41N9 (419.3485)


   

(+)-Lepadin H

(+)-Lepadin H

C26H45NO3 (419.3399)


   
   

Octadecanamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-

Octadecanamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-

C26H45NO3 (419.3399)


   

Methyl 3-heneicosyl-1H-pyrrole-2-carboxylate-Methyl 3-alkylpyrrole-2-carboxylates

Methyl 3-heneicosyl-1H-pyrrole-2-carboxylate-Methyl 3-alkylpyrrole-2-carboxylates

C27H49NO2 (419.3763)


   

(±)N-(2-fluro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

(±)N-(2-fluro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

C27H46FNO (419.3563)


   

(±)N-(2-fluro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

(±)N-(2-fluro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

C27H46FNO (419.3563)


   

(5E,7E)-(3S,24R)-[6,19,19-trideuterio-]-9,10-seco-5,7,10(19)-cholestatriene-3,24,25-triol

(5E)-(24R)-24,25-dihydroxy-[6,19,19-trideutrio]vitamin D3 / (5E)-(24R)-24,25-dihydroxy-[6,19,19-trideutrio]cholecalciferol

C27H41D3O3 (419.3479)


   

(+/-)-2,16,16-trimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethyamine

(+/-)N-(2-fluro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

C27H46FNO (419.3563)


   

(+/-)N-(2-fluro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

(+/-)-2,17,17,-trimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethylamine

C27H46FNO (419.3563)


   

N-oleoyl histidine

N-(9Z-octadecenoyl)-histidine

C24H41N3O3 (419.3148)


   

Type IV cyanolipid 22:0 ester

1-docosanoyl-(1-cyano-2-methylprop-2-en-1-ol)

C27H49NO2 (419.3763)


   

Type III cyanolipid 22:0 ester

Docosanoic acid, 3-cyano-2-methyl-2-propen-1-yl ester

C27H49NO2 (419.3763)


   

(+/-)-2,16,16-trimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethyamine

(+/-)N-(2-fluoro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine

C27H46NOF (419.3563)


   

(+/-)-2,17,17,-trimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethylamine

(+/-)-2,17,17,-trimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethylamine

C27H46NOF (419.3563)


   

NA 26:4;O2

N-[2-(3,4-dihydroxyphenyl)ethyl]-octadecanamide

C26H45NO3 (419.3399)


   

NAT 20:0

N-eicosanoyl taurine

C22H45NO4S (419.3069)


   

(1R,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]-1-deuterioethylidene]-4-(dideuteriomethylidene)cyclohexane-1,3-diol

(1R,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]-1-deuterioethylidene]-4-(dideuteriomethylidene)cyclohexane-1,3-diol

C27H41D3O3 (419.3479)


   

N-(4-Hydroxy-3-methoxybenzyl)octadecanamide

N-(4-Hydroxy-3-methoxybenzyl)octadecanamide

C26H45NO3 (419.3399)


   

3-[Dimethyl(octadecyl)ammonio]-1-propanesulfonate

3-[Dimethyl(octadecyl)ammonio]-1-propanesulfonate

C23H49NO3S (419.3433)


   

N-Stearoyldopamine

N-Stearoyldopamine

C26H45NO3 (419.3399)


   

N-icosanoyltaurine

N-icosanoyltaurine

C22H45NO4S (419.3069)


A fatty acid-taurine conjugate derived from icosanoic acid.

   

3-(1H-imidazol-5-yl)-2-[[(E)-octadec-9-enoyl]amino]propanoic acid

3-(1H-imidazol-5-yl)-2-[[(E)-octadec-9-enoyl]amino]propanoic acid

C24H41N3O3 (419.3148)


   

(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octadeca-9,12,15-trienamide

(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octadeca-9,12,15-trienamide

C26H45NO3 (419.3399)


   

(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxyoctan-2-yl)octadeca-6,9,12,15-tetraenamide

(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxyoctan-2-yl)octadeca-6,9,12,15-tetraenamide

C26H45NO3 (419.3399)


   

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexadeca-7,10,13-trienamide

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexadeca-7,10,13-trienamide

C26H45NO3 (419.3399)


   

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxydecan-2-yl)hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxydecan-2-yl)hexadeca-4,7,10,13-tetraenamide

C26H45NO3 (419.3399)


   
   

SPHP(22:1)

SPHP(m22:1)

C22H46NO4P (419.3164)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Dopamine 18:0

NA-Dopamine 18:0

C26H45NO3 (419.3399)


   

NA-His 18:1(9Z)

NA-His 18:1(9Z)

C24H41N3O3 (419.3148)


   

NA-Histamine 21:0

NA-Histamine 21:0

C26H49N3O (419.3875)


   

NA-Ile 20:3(8Z,11Z,14Z)

NA-Ile 20:3(8Z,11Z,14Z)

C26H45NO3 (419.3399)


   

NA-Leu 20:3(8Z,11Z,14Z)

NA-Leu 20:3(8Z,11Z,14Z)

C26H45NO3 (419.3399)


   

NA-Taurine 20:0

NA-Taurine 20:0

C22H45NO4S (419.3069)


   

(2s,3r,4as,5s,8ar)-5-[(5r)-5-hydroxyoctyl]-2-methyl-decahydroquinolin-3-yl (2e,4e)-octa-2,4-dienoate

(2s,3r,4as,5s,8ar)-5-[(5r)-5-hydroxyoctyl]-2-methyl-decahydroquinolin-3-yl (2e,4e)-octa-2,4-dienoate

C26H45NO3 (419.3399)


   

methyl 3-henicosyl-1h-pyrrole-2-carboxylate

methyl 3-henicosyl-1h-pyrrole-2-carboxylate

C27H49NO2 (419.3763)


   

(2z,4z)-22-hydroxy-1-(piperidin-1-yl)docosa-2,4-dien-1-one

(2z,4z)-22-hydroxy-1-(piperidin-1-yl)docosa-2,4-dien-1-one

C27H49NO2 (419.3763)


   

(2r,3r,4as,5s,8ar)-5-[(5r)-5-hydroxyoctyl]-2-methyl-decahydroquinolin-3-yl (2e,4e)-octa-2,4-dienoate

(2r,3r,4as,5s,8ar)-5-[(5r)-5-hydroxyoctyl]-2-methyl-decahydroquinolin-3-yl (2e,4e)-octa-2,4-dienoate

C26H45NO3 (419.3399)


   

22-hydroxy-1-(piperidin-1-yl)docosa-2,4-dien-1-one

22-hydroxy-1-(piperidin-1-yl)docosa-2,4-dien-1-one

C27H49NO2 (419.3763)


   

5-(5-hydroxyoctyl)-2-methyl-decahydroquinolin-3-yl octa-2,4-dienoate

5-(5-hydroxyoctyl)-2-methyl-decahydroquinolin-3-yl octa-2,4-dienoate

C26H45NO3 (419.3399)